Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-10 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 5e-06 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |